The malaria candidate vaccine liver stage antigen-3 is highly conserved in Plasmodium falciparum isolates from diverse geographical areas

Malaria Journal

Volumn 8, Issue 1, 2009, Pages

  Prieur, Eric ^a   Druilhe, Pierre ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER STAGE ANTIGEN 3; MALARIA VACCINE; PARASITE ANTIGEN; SUBUNIT VACCINE; UNCLASSIFIED DRUG; LIVER STAGE SPECIFIC ANTIGEN, PLASMODIUM; LIVER STAGE-SPECIFIC ANTIGEN, PLASMODIUM;

ARTICLE; BRAZIL; COMOROS; CORRELATION ANALYSIS; GENE LOCUS; GENETIC CONSERVATION; GENETIC POLYMORPHISM; GENETIC STABILITY; GENETIC VARIABILITY; GENOME ANALYSIS; GEOGRAPHIC DISTRIBUTION; MALARIA; NONHUMAN; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; SENEGAL; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STRAIN DIFFERENCE; THAILAND; ANIMAL; CAPILLARY ELECTROPHORESIS; GENETICS; GENOME; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; MOLECULAR GENETICS;

ANIMALS; ANTIGENS, PROTOZOAN; BRAZIL; COMOROS; ELECTROPHORESIS, CAPILLARY; GENOME, PROTOZOAN; MALARIA VACCINES; MALARIA, FALCIPARUM; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SENEGAL; SEQUENCE ANALYSIS; THAILAND;

EID: 72849142775     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-247     Document Type: Article

References (24)

1. The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. CA Guerra PW Gikandi AJ Tatem AM Noor DL Smith SI Hay RW Snow, PLoS Med 2008 5 38
2. Imported malaria in a cosmopolitan European city: a mirror image of the world epidemiological situation. JP Millet P Garcia de Olalla P Carrillo-Santisteve J Gascon B Trevino J Munoz IPJ Gomez J Cabezos A Gonzalez Cordon JA Cayla, Malar J 2008 7 56
3. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. SL Hoffman LM Goh TC Luke I Schneider TP Le DL Doolan J Sacci P de la Vega M Dowler C Paul DM Gordon JA Stoute LW Church M Sedegah DG Heppner WR Ballou TL Richie, J Infect Dis 2002 185 1155 1164
4. Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. KM Van Buskirk MT O'Neill P De La Vega AG Maier U Krzych J Williams MG Dowler JB Sacci Jr N Kangwanrangsan T Tsuboi NM Kneteman DG Heppner Jr BA Murdock SA Mikolajczak AS Aly AF Cowman SH Kappe, Proc Natl Acad Sci USA 2009 106 13004 13009
5. How to select Plasmodium falciparum pre-erythrocytic antigens in an expression library without defined probe. C Marchand P Druilhe, Bull World Health Organ 1990 68 Suppl 158 164
6. Plasmodium falciparum: D260, an intraerythrocytic parasite protein, is a member of the glutamic acid dipeptide-repeat family of proteins. DA Barnes W Wollish RG Nelson JH Leech C Petersen, Exp Parasitol 1995 81 79 89
7. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. P Daubersies AW Thomas P Millet K Brahimi JA Langermans B Ollomo L BenMohamed B Slierendregt W Eling A Van Belkum G Dubreuil JF Meis C Guérin-Marchand S Cayphas J Cohen H Gras-Masse P Druilhe, Nat Med 2000 6 1258 1263
8. Cross-reactive antigenic determinants present on different Plasmodium falciparum blood-stage antigens. D Mattei K Berzins M Wahlgren R Udomsangpetch P Perlmann HW Griesser A Scherf B Muller-Hill S Bonnefoy Guillotte G Langsley L Pereira da Silva O Mercereau-Puijalon, Parasite Immunol 1989 11 15 29
9. Cytoadherence of knobless Plasmodium falciparum-infected erythrocytes and its inhibition by a human monoclonal antibody. R Udomsangpetch M Aikawa K Berzins M Wahlgren P Perlmann, Nature 1989 338 763 765
10. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees. L BenMohamed H Gras-Masse A Tartar P Daubersies K Brahimi M Bossus A Thomas P Druilhe, Eur J Immunol 1997 27 1242 1253
11. Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent inducers of B helper, T helper and cytolytic T cell responses in mice. BL Perlaza JP Sauzet AT Balde K Brahimi A Tall G Corradin P Druilhe, Eur J Immunol 2001 31 2200 2209
12. Immunogenicity and protective efficacy of Plasmodium falciparum liver-stage Ag-3 in Aotus lemurinus griseimembra monkeys. BL Perlaza C Zapata AZ Valencia S Hurtado G Quintero JP Sauzet K Brahimi C Blanc M Arévalo-Herrera P Druilhe S Herrera, Eur J Immunol 2003 33 1321 1327
13. Evidence for multiple B- and T-cell epitopes in Plasmodium falciparum liver-stage antigen 3. A Toure-Balde BL Perlaza JP Sauzet M Ndiaye G Aribot A Tall C Sokhna C Rogier G Corradin C Roussilhon P Druilhe, Infect Immun 2009 77 1189 1196
14. Analysis of intra-hepatic peptide-specific cell recruitment in mice immunised with Plasmodium falciparum antigens. A Hebert JP Sauzet M Lebastard MN Ungeheuer P Ave M Huerre P Druilhe, J Immunol Methods 2003 275 123 132
15. Usefulness of the recombinant liver stage antigen-3 for an early serodiagnosis of Plasmodium falciparum infection. HW Lee SU Moon HS Ryu YJ Kim SH Cho GT Chung K Lin BK Na Y Kong KS Chung TS Kim, Korean J Parasitol 2006 44 49 54
16. Genetic polymorphism in Plasmodium falciparum vaccine candidate antigens. RC Mahajan U Farooq ML Dubey N Malla, Indian J Pathol Microbiol 2005 48 429 438 16366089
17. Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum. M Plebanski KL Flanagan EA Lee WH Reece K Hart C Gelder G Gillespie M Pinder AV Hill, Immunity 1999 10 651 660
18. Genome sequence of the human malaria parasite Plasmodium falciparum. MJ Gardner N Hall E Fung O White M Berriman RW Hyman JM Carlton A Pain KE Nelson S Bowman IT Paulsen K James JA Eisen K Rutherford SL Salzberg A Craig S Kyes MS Chan V Nene SJ Shallom B Suh J Peterson S Angiuoli M Pertea J Allen J Selengut D Haft MW Mather AB Vaidya DM Martin AH Fairlamb MJ Fraunholz DS Roos SA Ralph GI McFadden LM Cummings GM Subramanian C Mungall JC Venter DJ Carucci SL Hoffman C Newbold RW Davis CM Fraser B Barrell, Nature 2002 419 498 511
19. Plasmodium falciparum: genetic polymorphism in apical membrane antigen-1 gene from Indian isolates. V Rajesh VK Singamsetti S Vidya M Gowrishankar M Elamaran J Tripathi NB Radhika D Kochar A Ranjan SK Roy A Das, Exp Parasitol 2008 119 144 151
20. Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3. M Aidoo A Lalvani SC Gilbert JT Hu P Daubersies N Hurt HC Whittle P Druihle AV Hill, Infect Immun 2000 68 227 232
21. Malaria parasite pre-erythrocytic stage infection: gliding and hiding. AM Vaughan AS Aly SH Kappe, Cell Host Microbe 2008 4 209 218
22. Local control of the immune response in the liver. PA Knolle G Gerken, Immunol Rev 2000 174 21 34
23. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. C Roussilhon C Oeuvray C Muller-Graf A Tall C Rogier JF Trape M Theisen A Balde JL Perignon P Druilhe, PLoS Med 2007 4 320
24. Molecular basis for evasion of host immunity and pathogenesis in malaria. R Ramasamy, Biochim Biophys Acta 1998 1406 10 27